Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Argoff

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Headache and Pain|November 27, 2025
Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraineFawad A Khan, Steven P Herzog, Ryan M Smith, et al.
The Journal of Headache and Pain|November 28, 2025
Real-world effectiveness of eptinezumab in chronic migraine-increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fogCharles Argoff, Fawad A Khan, Steven P Herzog, et al.
Pain|February 13, 2019
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back painJohn Markman, Jeffrey Gudin, Richard Rauck, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back PainAbhilasha Ramasamy, Mona L Martin, Steven I Blum, et al.
Pain Medicine (Malden, Mass.)|July 31, 2019
Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS)Jeffrey Gudin, Richard Rauck, Charles Argoff, et al.
Pain Medicine (Malden, Mass.)|June 15, 2012
Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic painJohn F Peppin, Steven D Passik, Joseph E Couto, et al.
Postgraduate Medicine|May 12, 2016
Rethinking chronic pain in a primary care settingSteven Stanos, Marina Brodsky, Charles Argoff, et al.
Pain|February 13, 2018
Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 1-the Patient Assessment for Low Back Pain - Symptoms (PAL-S)Mona L Martin, Steven I Blum, Hiltrud Liedgens, et al.
Anesthesia and Analgesia|February 16, 2019
American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid TherapyDavid A Edwards, Traci L Hedrick, Jennifer Jayaram, et al.
Pain Medicine (Malden, Mass.)|January 29, 2019
Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel ReportKurt Kroenke, Daniel P Alford, Charles Argoff, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Headache and Pain|November 27, 2025
Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraineFawad A Khan, Steven P Herzog, Ryan M Smith, et al.
The Journal of Headache and Pain|November 28, 2025
Real-world effectiveness of eptinezumab in chronic migraine-increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fogCharles Argoff, Fawad A Khan, Steven P Herzog, et al.
Pain|February 13, 2019
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back painJohn Markman, Jeffrey Gudin, Richard Rauck, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back PainAbhilasha Ramasamy, Mona L Martin, Steven I Blum, et al.
Pain Medicine (Malden, Mass.)|July 31, 2019
Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS)Jeffrey Gudin, Richard Rauck, Charles Argoff, et al.
Pain Medicine (Malden, Mass.)|June 15, 2012
Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic painJohn F Peppin, Steven D Passik, Joseph E Couto, et al.
Postgraduate Medicine|May 12, 2016
Rethinking chronic pain in a primary care settingSteven Stanos, Marina Brodsky, Charles Argoff, et al.
Pain|February 13, 2018
Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 1-the Patient Assessment for Low Back Pain - Symptoms (PAL-S)Mona L Martin, Steven I Blum, Hiltrud Liedgens, et al.
Anesthesia and Analgesia|February 16, 2019
American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid TherapyDavid A Edwards, Traci L Hedrick, Jennifer Jayaram, et al.
Pain Medicine (Malden, Mass.)|January 29, 2019
Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel ReportKurt Kroenke, Daniel P Alford, Charles Argoff, et al.
Pageof 6